Author: Joel Selzer

Watching Our Educational Partners Succeed: Agile Design Made Easy

In the four years since the launch of the ArcheMedX platform and the introduction of the Learning Actions Model we have continually demonstrated how more effective education (with greater data utilization) can lead to significantly improved outcomes over traditional forms of online medical education.

In addition to the extensive bench marking data that demonstrate how the learning actions model is so effective, we love asking our education partners why they have been so successful using the ArcheMedX platform.  Over the next few blog posts we will highlight more of these success stories to help illustrate the outcomes our partners are achieving by partnering with ArcheMedX.

Introducing Antidote Education Company…

Antidote Education Company has been powering their Activities with the ArcheMedX platform for several years now, with more than 3,200 learners completing Activities across multiple Initiatives.  Working with the ArcheMedX team, Antidote has taken advantage of the platform’s ability to deliver an agile educational design within the ArcheViewer that not only creates a more effective learning experience and improves overall outcomes but makes it much easier to demonstrate success and identify additional unmet learner needs.  To better understand Antidote’s experience and achievements, let’s look a little deeper at one set of initiatives.

In 2015 the Antidote team launched New Horizons: Effective Management of Acute Heart Failure.  While the initial launch demonstrated initial success in-line with historical benchmarks, Matt Fleming, Vice President at Antidote Education Company, thought that key data generated from the Activities revealed an opportunity to enhance the interventions by making simple changes through the platform’s agile tools.  “Learners were missing a key point of the education and incorrectly answering part of the activity assessment,” says Matt.  Using the Plan-Do-Study-Act (PDSA), Matt added several targeted learning moments including educator notes and a new poll question to clarify and augment the learning experience.  These changes resulted in improved outcomes and provided critical, actionable data for future initiatives.

For the next initiative, Matt and the team at Antidote leveraged data and insights from the initial education to inform the needs assessment, creating a clear and concise picture of the need for additional education in heart failure.  That educational initiative, The Beat Goes On: Emergency Treatment of Acute Decompensating Heart Failure, was successfully funded and launched in 2017 and again, Matt and his team utilized an agile educational design and the framework of PDSA to structure changes based on formative data generated by the Activities.  Once again, the ability to quickly and easily make changes in the content and the various learning moments within the Activities showed welcome improvements in overall educational outcomes.

“Our relationship with the ArcheMedX team has been a true partnership”, says Matt.  “The ability to utilize agile design and development, to understand what is and is not working, in real-time, and to effectively make modifications in our education to improve the overall outcomes, has been a crucial element in our success with the ArcheMedX platform: something that we have been unable to do with other educational platforms.  And the ArcheMedX team has been tremendous.  They are always willing to apply their depth of expertise in solving any problem.  They truly want us to be successful.”

Congratulations to Matt and the Antidote team on their agile approach to delivering more effective education that allows greater data utilization and, ultimately, improved learner outcomes.

If you would like to hear more about the use of agile educational design, join Matt Fleming from Antidote and Michelle Tyner from ArcheMedX for an upcoming webinar:

 

Agile Continuing Education in Action: A Case Study

Thursday December 7th

at

1:00pm Eastern

Register for Webinar by Clicking This Link

 

Hosted by:

 

 

Continue Reading

ArcheMedX Growth Trajectory Accelerates, Attracting More Capital and Expanding Leadership Team

$2.5 million equity financing to support product development and scale up marketing for award-winning healthcare digital training and analytics platform

​​ArcheMedX, a healthcare informatics and e-learning technology company, has experienced explosive growth and attracted $2.5 million in equity financing to accelerate the company’s transformation of online health professional education and training.

In the past year, ArcheMedX has doubled their customer base of academic medical centers, pharmaceutical industry leaders, professional societies, and medical education companies that utilize their award-winning digital training platform. The company’s suite of digital learning and analytics products now powers more than 400 interactive and data-driven online training activities, collecting valuable insights from tens of thousands of clinicians, and improving the knowledge and competence of healthcare professionals at more than four times the level of traditional online education.

To support this increasing momentum, ArcheMedX recently closed $2.5 million in equity financing led by prominent early stage investors Jaffray Woodriff and Greyson Williams. This additional capital will be utilized to meet expanding product demand while positioning the company for long term growth. Funds will be used to expand engineering to deliver an extended product roadmap and to build a sales and marketing organization that will accelerate progress.

“ArcheMedX is transforming the way healthcare organizations design, deliver, and analyze their online education programs,” says Joel Selzer, co-founder and CEO of ArcheMedX. With these additional resources we will expand our impact across the greater healthcare industry, ultimately helping millions of patients receive better care at lower costs.”

Leadership Team Expands

Since closing the financing, ArcheMedX has added three industry veterans to the leadership team and is currently recruiting for a variety of engineering, product management, and marketing positions located at the Company’s headquarters in Charlottesville, VA.

“We have been fortunate to attract some incredible leaders with the expertise, passion and vision to architect our next generation of interactive educational solutions,” says Brian S. McGowan, PhD, Co-Founder and Chief Learning Officer.

Gregg Carrier, formerly Vice President of Engineering and Chief Operating Officer at Willow Tree, has joined ArcheMedX as Chief Technology Officer. He brings to the company 20 years of software engineering and technology leadership experience, including previous tenures with Sony Computer Entertainment, Wordnik, DreamWorks Animation and Branagh Information Group.

Lucian Taylor, who has led product development at Microsoft, Autodesk, Rosetta Stone, and PDR Network, joins ArcheMedX as Vice President of Product Management. Kenny Cox, a very well-respected industry leader and former Vice President of myCME, has been recruited to serve as Vice President of Continuing Medical Education to expand the company’s core medical education market.

About ArcheMedX

ArcheMedX is a healthcare informatics and e-learning technology company that is transforming online education and training through a data-driven approach to learning. By leveraging nearly five decades of cognitive science and years of applied research, the ArcheMedX team developed the ArcheViewer, an award-winning e-learning and analytics platform that enables educators to simplify the design, delivery, and analysis of more interactive and effective online learning experiences.

ArcheMedX currently partners with dozens of healthcare organizations (academic medical centers, pharmaceutical industry leaders, professional societies, and medical education companies) to power and analyze hundreds of digital training experiences available across dozens of clinical and non-clinical areas.  Learners who participate in ArcheViewer-powered education have been found to improve their knowledge and competence at a level four-to-six times greater than traditional online education. To learn more, visit www.archemedx.com.

Continue Reading

When Terror Strikes Charlottesville, What is Our Moral Obligation?

“Timid men prefer the calm of despotism to the tempestuous sea of liberty.” – Thomas Jefferson

The ArcheMedX offices are only a block away from where the horrific attack took place in Charlottesville this weekend. While these events and images ripped through our community, we are very fortunate that the members of our team, their families, and friends are safe. To all of our colleagues and partners across the country that reached out to express their concern and support, we thank you!

While our team was physically unharmed, each of us has been impacted by the terror that struck our idyllic college town and vibrant business community. Charlottesville is an incredible city to live and work in and there is simply no place for the racism, anti-Semitism, bigotry, and hate that outsiders brought to our doorstep. These despicable acts cannot be tolerated anywhere in America.

Although the healing has quietly begun here in Charlottesville, our country has a difficult journey ahead. I am hopeful that our better angels will prevail, but the outcome of this struggle between good and evil cannot be left to chance.

The attacks of this past weekend are only the latest assault on our democracy and values. Each of us, especially those among us in leadership positions, must speak out forcefully and unequivocally and, when necessary, hold our employees, colleagues, business partners, and even our friends and family accountable for their words and actions.

To do otherwise is to abdicate our moral and fiduciary responsibilities.

Joel Selzer

Co-Founder & CEO

ArcheMedX

Continue Reading

Academy of Continued Healthcare Learning, ProPatient, and ArcheMedX Extend Collaboration to Improve Shared Decision Making in Patient Care

Charlottesville, VA, May 23, 2017 (Newswire) –​​​The Academy of Continued Healthcare Learning (ACHL), ProPatient, and ArcheMedX have launched a series of integrated online learning programs that have successfully educated and empowered both healthcare providers and patients/caregivers to share decision making in addressing the challenges of treating Idiopathic Pulmonary Fibrosis (IPF) and Non-Small Cell Lung Cancer (NSCLC).

As scientific discoveries accelerate and our healthcare system becomes more complex, it is critical for clinicians and patients to communicate and collaborate to optimize patient-centric care. While the benefits of shared decision making are well established, it is far from the norm and significant efforts are need to ensure that all stakeholders are comfortable, capable, and committed.

“Online learning is a cost-effective way to provide physicians with on-demand access to the latest clinical advances and a trusted channel to educate and empower patients to participate in their care,” said Lisa Keckich, Executive Director at ACHL. She added, “ACHL entered into this partnership to assess whether an integrated educational approach would facilitate shared decision making for complex diseases like IPF and lung cancer. The success of these initiatives demonstrates the power of the ArcheMedX and ProPatient platforms to educate and motivate clinicians and patients to work collaboratively and has established a model we eagerly anticipate extending to additional clinical areas.”

Through these interventions clinicians are better prepared to guide their patients through a shared decision making process and patients are better informed and more empowered to participate in their care.

Improving Engagement with IPF Patients

Since launching in December 2016, more than a thousand clinicians and patients have participated in the educational program, enhancing multidisciplinary approaches to care and addressing the unique and evolving needs of patients with IPF.

80% of clinicians engaged by the program reported making changes to their shared decision-making practices since participating. Furthermore, 85% of IPF patients reported that the patient education activity helped them better understand IPF.(Insert one line with patient data/results)

You can learn more about this IPF program here.

Improving Engagement with Lung Cancer Patients

Since launching in June 2016, thousands of lung cancer clinicians and patients have participated in the educational program, enhancing personalized approaches to care and simplifying important challenges related to diagnosis and treatment.

90% of clinicians engaged by the program reported that they had increased the frequency in which they engage their patients with NSCLC in shared decision-making since participating. 58% of patients feel that they learned from the activity and were better able to understand their diagnosis.(Insert one line with patient data/results)

You can learn more about this NSCLC program here.

*These interventions would not be possible without commercial support. The IPF program is supported by an educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Genentech, Inc. and the NSCLC program is supported by an educational grant from Genentech, Inc.

About ACHL:

ACHL is an-award winning provider of continuing medical education programs.  Its mission is to design, develop, and implement quality continuing education activities that have a positive influence on the way healthcare is practiced and ultimately, to improve the quality of care provided to patients.

About ProPatient:

ProPatient is a patient-focused, online educational platform that utilizes interactive video and engaging simulation to provide patients with the opportunity to ask questions of a virtual clinician and role-play different scenarios to improve their skills.

About ArcheMedX:

ArcheMedX is a healthcare informatics and e-learning technology company that is transforming online education through a data-driven approach to learning. By leveraging nearly five decades of cognitive science and years of applied research, the ArcheMedX team has developed an award-winning e-learning and analytics platform that simplifies the design, delivery, and analysis of online education and training across the healthcare industry.

ArcheMedX currently partners with dozens of healthcare organizations (national medical societies, leading academic medical centers, major pharmaceutical firms, and global medical education companies) to power and analyze hundreds of more engaging and interactive learning experiences available across dozens of clinical and non-clinical areas. Learners who participate in ArcheMedX-powered education have been found to improve their knowledge and competence at a level four-to-six times greater than traditional online education. To learn more, visit www.archemedx.com.

Continue Reading

Dynamic and More Flexible Expansion Planned for Strategies for Success as a Patient-Centered Medical Home Initiative

BALTIMORE, MD—May 22, 2017—The National Committee for Quality Assurance (NCQA) and its collaborating partners, Med-IQ and ArcheMedX, are pleased to announce a more dynamic, engaging, and flexible initiative being developed in response to the successes and lessons learned from the 2015-2017 Strategies for Success as a Patient-Centered Medical Home (Strategies for Success).

The new 2017-2019 expansion will build on the first phase by placing greater emphasis on quality measures, enhanced collaboration, and care coordination, while setting the foundation for future quality improvement initiatives within the NCQA PCMH network of clinical practices.

The expansion will create therapeutic area–themed months to align with national awareness campaigns and initiatives. During each month and throughout the life of the initiative, education will be developed to address outstanding practice challenges and educational needs identified by learners in the first phase. Additional enhancements include:

  • Increased accessibility through a live and enduring Webinar series
  • Greater focus on quality measures and ways to implement processes to focus on these measures
  • New ways to share best practices across PCMH practices
  • Continuous engagement through the ArcheTeam platform and the use of more dynamic content models that provide greater flexibility in access to practical information

The first phase of Strategies for Success enrolled nearly 600 practices, averaging more than 3 team members per practice and demonstrating significant improvements in many pre-specified metrics including:

  1. Increased use of standardized screening tools to identify patients with major depressive disorder in the primary care setting
  2. Increased awareness and action planning of patients with type 2 diabetes who are not at goal
  3. Increased discussions between patients and providers related to lower urinary tract symptoms
  4. Increased testing for HCV among patients born between 1945 and 1965
  5. Increased development of individualized treatment plans for patients who are overweight
  6. More frequent calculation of patients’ 10-year risk of developing cardiovascular disease

The Strategies for Success initiative is unlike any educational programming that I’ve witnessed in my nearly 20 years in continuing professional development,” said William Mencia, MD, Vice President of Education and Medical Affairs at Med-IQ. “Not only is this initiative transformative in the way that it addresses both the clinical and process-oriented needs of the practices, but it does so in a manner that engages the clinical and non-clinical staff and gets the entire practice communicating and collaborating to improve patient outcomes.”

By leveraging a more dynamic and flexible implementation of the ArcheTeam platform, NCQA and MedIQ have an even greater opportunity to support the types of team-based, collaborative learning that have been shown to be critical in supporting practice improvement,” said Brian S. McGowan, PhD, FACEhp, Chief Learning Officer at ArcheMedX. “Phase one demonstrated that team-based learning is both unique and necessary. In phase two, we intend to increase the scale of the initiative and drive even greater engagement and accessibility to support the team-based transformation to a quality culture.”

For more information, please look for our partners at the Alliance Industry Summit in Philadelphia this week or contact William Mencia, Vice President, Education and Medical Affairs at Med-IQ at wmencia@med-iq.com or 443-543-5135.

Continue Reading

Its Been a Remarkable Year at ArcheMedX

Although its only October and those of us with children (Max is 7 months old now) are eagerly awaiting a fun filled Halloween, 2016 has already been a remarkable year both personally and for ArcheMedX in terms of customer growth, product evolution, educational impact, and ground breaking research. To elaborate on these highlights (and more) we have invited industry partners and interested parties to attend a brief Webinar.

The one-hour session will provide an update on our progress and plans for the future, covering the following topics:

  1. Our Continued Growth (5 minutes)
  2. Brief Data Review (10 minutes)
  3. Recent Product Updates (10 minutes)
  4. Product Roadmap (10 minutes)
  5. Best Practices (10 minutes)
  6. Q&A (15 minutes)
If you are interested in joining us, please register for one of two upcoming Webinar dates:

October 27th 

@11am ET
Register Button
or

November  1st

@2pm ET
Register Button

As a sneak-peek, here are a few of the items

we will explore on the Webinar:

Scale of Growth
ArcheMedX has now powered nearly 350 Activities for 20+ Education Partners, receiving grant support from 30+ Commercial Supporters (i.e., pharmaceutical firms). These Activities have enabled more than 15,000 Learners (primarily clinicians) to take 40,000 Learning Actions (i.e., notes, reminders, searches, responding to faculty nudges, etc). Thanks to the medical education community’s vision, planning, support, and collaborative efforts, we continue to grow!

archemedx-2016-growth

Recently launched Activities include Zika education, AAP’s annual Influenza curriculum, a Clinical Trials curriculum with UVA, a Patient Safety curriculum with UNTHSC, an expanded PCMH team-based learning experience with NCQA, and dozens of additional Activities in topics ranging from cardiology, to oncology, to rheumatology, to neurology, to endocrinology, and many, many more!

Data Review
Our second Research White Paper (download) released earlier this year demonstrated that the more engaged a learner is throughout the educational experience the greater the educational impact. The data also showed that the more educators adhere to best practices in designing and spacing learning moments the higher the level of engagement. Of interesting note, these results were materially consistent regardless of clinical area or learner specialty!

 

Recent Product Updates
Throughout 2016 we continued to invest in product enhancements based on continued feedback from the educational community. For example, we streamlined and simplified the process of designing nudges and learning moments, introduced new educator tools to drive reflection and capture qualitative data, and added the ability to clone and copy Assessments and Evaluations.

 

Product Roadmap
In 2017, ArcheMedX will release the next generation of the ArcheViewer and ArcheTeam products, introducing new features and tools to increase learner engagement and collaboration, infuse additional content types into education, and deliver a truly optimized mobile learning experience. And, we will continue to work towards the beta version of ArcheInsights – the industry’s first fully automated outcomes, analysis, and research platform.

 

Joel Selzer
CEO, ArcheMedX
Continue Reading

The American Academy of Pediatrics and ArcheMedX Extend Collaboration and Prepare Pediatricians for the Zika Virus

With the threat of the Zika virus spreading during the summer months, the American Academy of Pediatrics (AAP) has extended its collaboration with ArcheMedX to power an online educational program designed to prepare health care providers to more effectively screen, test, and care for pediatric patients exposed to and infected with the Zika virus.

Charlottesville, VA (August 29, 2016) – Today, the American Academy of Pediatrics (AAP) and ArcheMedX announce a new multi-year agreement to collaborate in the development and delivery of more interactive online education, including the recent launch of the Academy’s first online education program to prepare healthcare providers for the Zika virus. This newly released online learning program, Zika Virus: What Pediatricians Need to Know, is available free of charge to all 66,000 members of the AAP and to anyone who registers on the AAP website.

“With Zika virus confirmed in the United States, it’s critical for pediatricians to have access to the most up-to-date information on screening, testing and caring for children who have been infected,” said Yvonne Maldonado, MD, FAAP, vice chair of the AAP Committee on Infectious Diseases.AAP Zika Activity-White-small

The course is available on PediaLink, the Academy’s online learning system for continuing medical education activities. The Zika learning program presents an overview of the epidemiology of the Zika virus, risk factors for Zika virus infection, clinical manifestations of the Zika virus disease, and current guidance from AAP and the Centers for Disease Control and Prevention regarding screening, testing and caring for pediatric patients exposed to and infected with the Zika virus. Interspersed throughout the education are critical references (factsheets, guidelines, patient tools, etc), which can be viewed online and downloaded immediately by each learner. Due to the rapid increase in information about Zika in children becoming available as a result of increasing experience with Zika-affected children, pediatricians should supplement their Zika knowledge through updates provided by CDC and AAP on their websites.

According to the CDC, local transmission of the Zika virus has now been reported in several countries or territories in the Americas. There is recent evidence of local transmission of Zika virus in Florida, i.e. transmission from an infected human to a mosquito to another human. This makes it very likely that there will be additional cases of Zika infection due to local transmission within the United States, particularly in the southeastern states. In the current outbreak in Brazil, a marked increase in the number of infants born with microcephaly has occurred and Zika virus infections have been confirmed in some infants with microcephaly. Travelers to areas with ongoing outbreaks are at risk of becoming infected and spreading the virus to new areas, including the continental United States. Although the risk of widespread transmission of Zika virus in the United States is thought to be low, there will continue to be sporadic cases, including among pregnant women, infants and children.

The AAP’s Zika educational program is being delivered within the ArcheViewer, an interactive eLearning and data analysis platform developed by ArcheMedX, to provide clinicians a more efficient way to review and absorb key information on the Zika virus and to provide real-time feedback to AAP regarding each learner’s experience in practice screening, testing, and caring for pediatric patients.

Joel Selzer, CEO of ArcheMedX, commented, “We are honored to extend our relationship with one of the nation’s preeminent healthcare organizations and couldn’t be more pleased the American Academy of Pediatrics has once again entrusted ArcheMedX to power such critical education for its 66,000 members.”

ArcheViewer enables faculty to prompt learners to review additional resources, reflect, and respond to questions, making it simpler for learners to translate key recommendations into clinical practice. The platform allows learners to take notes synchronized to where they are in the module, submit questions to faculty, set personal reminders, and search relevant resources collated by faculty. As learners respond in the platform, data are collected, analyzed, and presented back to faculty through the ArcheViewer’s data dashboards. This approach enables the AAP team to assess the impact of their educational courses and to refine their presentations and resources as needed.

ArcheMedX Media Contact: Brian S. McGowan, Chief Learning Officer of ArcheMedX at brian@archemedx.com

AAP Media Contact: Noreen Stewart, nstewart@aap.org, 847-434-7944

About the American Academy of Pediatrics

The American Academy of Pediatrics is an organization of 66,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. For more information, visit www.aap.org or follow us at @AmerAcadPeds.

About ArcheMedX

ArcheMedX is a healthcare informatics and e-learning technology company that is transforming online education through a data-driven approach to learning. By leveraging nearly five decades of cognitive science and years of applied research, the ArcheMedX team developed the ArcheViewer, an award-winning e-learning and analytics platform, that enables educators to construct, deliver, and assess more engaging and effective online learning experiences.

ArcheMedX currently partners with dozens of healthcare organizations (national medical societies, leading academic medical centers, and global medical education companies) to power and analyze hundreds of Web-based learning experiences available across dozens of clinical areas. Learners who participate in ArcheViewer-powered education have been found to improve their knowledge and competence at a level nearly four times greater than traditional online education. To learn more, visithttp://www.archemedx.com.

Continue Reading

UNT Health Science Center and ArcheMedX Extend Collaboration To Improve Patient Safety

UNT Health Science Center and ArcheMedX today announced the development of a sustainable online curriculum of educational activities to address patient safety issues across the State of Texas and beyond.

Charlottesville, VA — August 23, 2016 — (PRWeb) More than 250,000 Americans die annually from preventable medical errors, recent data suggest, making medical errors the third leading cause of death in the United States. The number of Americans experiencing serious, but non-lethal, injury from preventable errors may be 10 to 20 times that number.

To help address the crisis, UNTHSC received legislative funding to establish the Institute for Patient Safety, which is dedicated to improving the quality and safety of health care in the region and throughout the nation.

“We believe that one crucial element of patient safety is timely and effective education for medical providers,” said Andrew Crim, Executive Director of Professional and Continuing Education at UNTHSC.

“For this reason, we believe our partnership with ArcheMedX, and its award-winning suite of data-driven, educational tools, is critical to ensuring we can deliver effective education to the health care community across Texas.”

Medical errors lead to an estimated $50 billion in added U.S. health care costs, and up to $1 trillion in lost human potential and contributions. These alarming statistics emphasize the urgent need for patients and health care professionals to work together to eliminate medical errors and to assure the highest quality of health care for everyone.

UNTHSC is nationally renowned for developing innovative educational programs, and the goal of our collaboration is to accelerate the pace at which the UNTHSC team can design, deliver, analyze and refine a sustainable curriculum of online education that addresses a critical gap in our nation’s health care system,” Joel Selzer, ArcheMedX CEO. “This is the best kind of partnership – one that combines the recognized strengths of each organization to create real and meaningful change, in this case by enabling a more pervasive patient safety culture that mitigates preventable medical errors and saves lives through better education.”

Added Crim, “Collaborating with the ArcheMedX Team will also allow us to learn critical lessons about how our educational interventions are working and enable our team to rapidly optimize and refine our educational experiences over time.”

During the coming year, UNTHSC and ArcheMedX will identify and address patient safety issues throughout the state and develop and deliver a sustainable curriculum of more interactive, data-driven educational activities.UNTHSC Patient Safety Medication Errors_Medium

These activities will be powered by the ArcheViewer, an eLearning and analytics platform. The initial series of educational programs launched this summer with the first activities focusing on medication reconciliation. This series will be followed by courses in the fall on interprofessional communication, medication non-adherence and transitions of care.

To learn more about the Institute for Patient Safety and the Institute’s educational initiatives, visit https://www.unthsc.edu/institute-for-patient-safety/healthcare-quality-and-safety/.

To learn more about ArcheMedX and its data-driven approach to supporting online learning, contact Michelle Tyner at michelle@archemedx.com .

About the Institute for Patient Safety:

Recognizing the urgent need to improve patient safety, the UNT Health Science Center has created the Institute for Patient Safety, with generous support from the Texas State Legislature. Although led by UNTHSC, the Institute includes diverse health care and related institutions throughout the region, as well as institute fellows and scholars who represent a broad array of health care professionals, patients and advocates. Founding members of the institute include Texas Christian University, JPS Health Network and Cook Children’s Medical Center. This collaboration reflects a community-wide effort combining expertise from the fields of medicine, science, engineering, public health, nursing and patient experience.

About UNTHSC

UNT Health Science Center is a values-based graduate university located on 33 acres in the heart of Fort Worth’s Cultural District. Founded in 1970, the university has approximately 2,500 students across its five graduate schools: Texas College of Osteopathic Medicine, Graduate School of Biomedical Sciences, School of Public Health, School of Health Professions and the UNT System College of Pharmacy. Key areas of interprofessional strength include aging and Alzheimer’s disease, applied genetics, eye diseases, primary care and prevention. For more information, please visit www.unthsc.edu.

About ArcheMedX:

ArcheMedX is a health care informatics and e-learning technology company that is transforming online education through a data-driven approach to learning. By leveraging nearly five decades of cognitive science and years of applied research, the ArcheMedX team developed the ArcheViewer, an award-winning e-learning and analytics platform, that enables educators to construct, deliver, and assess more interactive and effective online learning experiences.

ArcheMedX currently partners with dozens of health care organizations (national medical societies, leading academic medical centers, and global medical education companies) to power and analyze hundreds of interactive, web-based learning experiences available across dozens of clinical areas. To learn more, visit www.archemedx.com.

 

Continue Reading

Celebrating Innovation in Charlottesville as ArcheMedX Named a Leading Tech Innovator by the Charlottesville Business Innovation Council (CBIC)

ArcheMedX is honored to be named a leading tech innovator by the Charlottesville Business Innovation Council (CBIC) and will be recognized later today at the 18th Annual CBIC Awards Gala hosted at the esteemed Boar’s Head Inn. This year’s Awards Gala is designed as an evening of inspiration celebrating #CVilleTech innovation and ArcheMedX joins a long list of notable past CBIC Gala Awards Finalists and Recipients such as Psikick, WillowTree, Maternity Neighborhood, Hotelicopter, Silverchair, MusicToday, and VividCortex to name just a few.

CBIC 2016 Awards Gala

This year ArcheMedX was recognized by CBIC for its collaboration with the National Committee for Quality Assurance (NCQA) for developing an innovative educational program to address the unique training needs of 11,000+ Patient-Centered Medical Home (PCMH) practices across the country. The program employs a blended approach of clinician-led regional workshops and an innovative team-based online learning experience, powered by ArcheMedX. To support this initiative and other collaborative training programs, ArcheMedX developed a new product, ArcheTeam, which NCQA is utilizing to dynamically create 11,000+ private and secure “learning communities of practice” that enable each PCMH to bring its clinical and administrative staff together to participate in training activities as a team.

NCQA_TEAM

 

The themes of “team work” and “collaboration” that led to this recognition are also the driving force behind bringing Charlottesville’s tech and innovation community together for this year’s Awards Gala. While Charlottesville has been known for nearly two hundred years as the home of Thomas Jefferson, Monticello, and the University of Virginia, in more recent years the region’s pristine natural beauty, burgeoning wine country, and acclaimed quality of life have gained widespread attention.

However, Charlottesville is also home to a thriving tech and innovation community and was recently named the fastest growing venture ecosystem in the United States by the National Venture Capital Association (NVCA). According to data published by NVCA and PricewaterhouseCoopers LLP (PwC) Charlottesville experienced the greatest rate of growth as measured by venture investment dollars with a 156.5 percent increase since 2010.

Those of us fortunate enough to live and work here over the past few years have seen Charlottesville’s evolution as an innovation hub accelerating, thanks in large part to the collaboration and continued team work across the University of Virginia, Darden’s iLab, UVA’s Licensing and Ventures Group (LVG), the Tom Tom Festival, HackCville, and of course the Charlottesville Business Innovation Council. Together, the community has forged an ever-strengthening bond around a common mission to encourage, promote, and support a vibrant ecosystem for entrepreneurs, innovators, and technologists to thrive in.

Please join us in celebrating the region’s continued success at the Gala tonight and making Charlottesville a vibrant home for ArcheMedX and all our fellow innovators.

Joel Selzer

CEO – ArcheMedX

 

 

Continue Reading

Learner Engagement is a Key to Educational Effectiveness

Over the past three years tens of thousands of clinician learners have participated in hundreds of ArcheMedX-powered Activities developed by the educational community. Analyzing the data generated across these diverse online educational interventions has revealed key insights into how the Learning Actions Model and award-winning ArcheViewer eLearning platform can be utilized to more effectively and efficiently transform online education.

For example, our initial data found that ArcheViewer-powered education resulted in completion rates (more than 75% on average) that were two-to-three times greater than traditional industry benchmarks. And research shared in the fall of 2015 and demonstrated that the more interactive nature of ArcheViewer-powered education is four-to-six times as effective as traditional online education.

Recently, the ArcheMedX team began working to examine a more expansive data set to answer increasingly complex and important questions. In other words, now that prior research has shown that the Learning Actions Model and ArcheViewer are two-to-three times as sticky (completion rates) and four-to-six times as effective (assessment performance) as traditional online education, the educational community can now begin to explore the key question, “Why does it work so well?”

The simple answer is “learner engagement”. After analyzing results across tens of thousands of learners and hundreds of online educational interventions, the data clearly demonstrates that the more engaged a learner is throughout the learning experience the greater the educational impact.

This chart shows 3,214 learners ranked by engagement level (as defined by the number of learning actions they took while consuming content in an ArcheViewer-powered Activity). We then analyzed their pre/post-test performance by quartile and compared the increase in effectiveness to the least engaged quartile of learners.

Our latest White Paper (download here) dives deeper into this data set and explores why learner engagement is so critical to educational effectiveness. The resulting analysis provides a series of best practices the educational community can leverage to optimize their online educational interventions.

As a sneak peek into these new data, three separate but connected research projects were undertaken. One in collaboration with the team at Antidote Education Company (Antidote), another in collaboration with the combined teams at AcademicCME and Postgraduate Institute for Medicine (PIM), and an internal project at ArcheMedX that analyzed data across hundreds of learning Activities and thousands of additional learners. The goal for this research was to better understand why the interactive educational interventions powered by the ArcheViewer have such transformational impact on learning and clinician learners. In short, we learned the following:

  1. By collecting and analyzing data from tens of thousands of learners participating in ArcheViewer-powered educational Activities we can move from simply measuring ‘if interventions work’ to more precisely determining ‘why and how they worked’, which in turn established a series of best practices the educational community can leverage.
  2. By comparing sub-populations of learners who engaged in ArcheViewer-powered learning experiences before and after intentional design improvements were made, the data suggests that the ArcheViewer suite of Activity Tools allows Partners to refine and optimize their interventions over time.
  3. By exploring two large, diverse data sets, the data determined that learner engagement – in keeping with the Learning Actions Model – is a critical determinant of educational effectiveness.
  4. By correlating a Partner’s approach to leveraging the Learning Actions Model and the average learner’s engagement across a sampling of Partners, the data have begun to define the optimal design intensity.
  5. And, by segmenting learner data by clinical specialty, the data demonstrated that specialty in-and-of-itself imparts minimal if any discernible difference in the ArcheViewer-powered learning experience or educational effectiveness.

In the end, these findings strengthen the resolve at ArcheMedX to empower the community of healthcare educators with a transformational approach to more effective online learning. Continuing this analysis and interpretation of learning data helps to ensure that each Activity and each learning experience Partners create provides the impact and value that the community is passionately dedicated to achieving.

To learn more about the direct implications of this research on the learning activities that you are designing please download the White Paper.

To schedule a demo of the ArcheMedX Learning Actions Model, the ArcheViewer, and the learning platform’s latest enhancements please contact the ArcheMedX Partner Support Team by emailing info@archemedx.com.

* Acknowledgements:

The interventions explored within this research and therefore the research itself would not have been possible without the direct research partnership with Antidote Educational Company and AcademicCME along with additional efforts of ACHL, AKHCME, American Academy of Pediatrics, Imedex, MedIQ, NACCME, NCQA, PIM, University of Nebraska, University of North Texas, and University of Virginia. Moreover, these interventions and this resource would not have been possible without the generous financial support from Astellas Pharma US, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, DAIICHI SANKYO, Exact Science, Genentech, Gilead Sciences, Covidien, Incyte, Jannsen Biotech, Lilly, Lundbeck, Merck, Novartis Pharmaceuticals, Novartis Oncology, Onyx Pharmaceuticals, Inc., an Amgen subsidiary, Otsuka Pharmaceutical, Pfizer, Pharmacyclics, PharmaEssentia, Prometheus Laboratories, Regeneron , Sanofi US, Seattle Genetics, Takeda, TESARO, USB.

Continue Reading